|
|
|||||||
Malignant Lymphomas |
* HMDS, Academic Unit of Haematology and Oncology, Leeds General Infirmary, Leeds, LS1 3EX, United Kingdom
° University of Oxford, Nuffield Department of Clinical Laboratory Sciences, LRF Lymphoma Antigens Programme, John Radcliffe Hospital, Oxford, UK;
# Epidemiology and Genetics Unit, University of York, York, UK
Correspondence: Sharon L Barrans, HMDS, Academic Unit of Haematology and Oncology, Leeds General Infirmary, Leeds, LS1 3EX, United Kingdom. Phone: international + 44.11.33926285. Fax: international +44.11.33926286. E-mail: sharonb{at}hmds.org.uk
Strong uniform expression of FOXP1 protein occurs in a subgroup of non-germinal centre (GC) diffuse large B-cell lymphomas (DLBCL). We have investigated gene rearrangement as a potential mechanism for deregulated expression of FOXP1 however, using FISH FOXP1 translocations were not found in any case with over-expression of the protein.
This article has been cited by other articles:
![]() |
P. J. Brown, S. L. Ashe, E. Leich, C. Burek, S. Barrans, J. A. Fenton, A. S. Jack, K. Pulford, A. Rosenwald, and A. H. Banham Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL Blood, March 1, 2008; 111(5): 2816 - 2824. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |